About
Femara 2.5mg Tablet is an anti‑cancer medicine belonging to the class of aromatase inhibitors. It is prescribed as supportive therapy following primary treatment or as first‑line therapy for postmenopausal women with early or advanced hormone receptor‑positive breast cancer. Since high estrogen levels can stimulate breast cancer growth, this medicine works by blocking aromatase, an enzyme involved in estrogen production, thereby reducing estrogen levels. This helps slow or stop the growth of cancer cells and prevent their spread to other parts of the body.
Inform your physician if you have not yet reached menopause, as Femara 2.5mg is not effective for premenopausal women. Because it lowers reproductive hormone levels, it is not recommended for menstruating women and may cause fertility issues. Regular monitoring of cholesterol levels is advised, as the medicine can raise cholesterol. It may also reduce bone mineral density, so discuss bone health monitoring with your doctor. Effective contraception should be used during treatment and for at least three weeks after the last dose.
Directions for use
This medicine should be administered by a doctor or nurse. Please do not attempt to self-administer it.
Side effects
- Decreased bone mineral density
- Fluid build‑up in lungs
- Decreased red blood cells
- Nausea and vomiting
- Dizziness, tiredness, and sleepiness
- Swelling in the face, eyes, feet, and legs
- Loss of appetite
- Breathing difficulty
- Constipation
- Hypertension
- Arthralgia
- Hot sweats and excessive sweating
- Muscle pain, bone pain, and joint stiffness
- Hypercholesterolemia (high cholesterol)
- Heart palpitation
- Diarrhoea
Safety Measures
Alcohol - Alcohol consumption is not recommended during treatment with Femara 2.5mg Tablet, as it may cause serious complications.
Pregnancy - Femara 2.5mg Tablet is highly unsafe during pregnancy, as it may harm the unborn baby. Consult your doctor if you are pregnant, think you might be pregnant, or are planning to become pregnant. Discuss effective contraceptive methods with your healthcare provider during treatment.
BreastFeeding - Breastfeeding is not safe while taking Femara 2.5mg Tablet, as the medicine may harm the baby. Avoid breastfeeding for at least three weeks after the last dose.
Liver - It is unknown whether Femara 2.5mg Tablet is safe for patients with liver problems. Inform your physician if you have any liver disease before starting treatment, and contact your doctor immediately if you develop any liver‑related symptoms.
Kidney - Femara 2.5mg Tablet is generally safe for patients with kidney disease, and no dose adjustment is usually required. However, there is limited information on its use in patients with end‑stage kidney disease. Consult your doctor for individual advice.
Disclaimer
Med E Hub is committed to delivering reliable, expert-reviewed information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!